Global Medical Imaging Reagents Market 2017-2021

医療画像用試薬の世界市場2017-2021

◆タイトル:Global Medical Imaging Reagents Market 2017-2021
◆商品コード:IRTNTR14974
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年10月30日
◆ページ数:95
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、医療画像用試薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、医療画像用試薬の世界市場規模及び予測、製品別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は医療画像用試薬の世界市場が2017-2021年期間中に年平均8.57%成長すると予測しています。当レポート上に記載されている主な企業は、Bayer、Bracco Diagnostics、GE Healthcare、Guerbet Group、Lantheus Medical Imaging等です。

About Medical Imaging Reagents
Medical imaging reagents are substances that are designed to enhance the imaging of specific organs, tissues, diseases, and physiological functions using medical imaging equipment to diagnose and monitor diseases. Medical imaging reagents are used in a wide range of imaging modalities such as X-ray, computed tomography (CT), ultrasound, single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI). Imaging reagents have improved the quality of medical imaging examinations.

Technavio’s analysts forecast the global medical imaging reagents market to grow at a CAGR of 8.57% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global medical imaging reagents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Medical Imaging Reagents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bayer
• Bracco Diagnostics
• GE Healthcare
• Guerbet Group
• Lantheus Medical Imaging

[Other prominent vendors]
• Cardinal Health
• Curium
• DONGKOOK
• Eli Lilly and Company
• Isologic Innovative Radiopharmaceuticals
• Jiangsu Hengrui Medicine
• Piramal Imaging
• SHINE Medical Technologies

[Market driver]
• Rising incidence of cardiovascular disorders and cancer
• For a full, detailed list, view our report

[Market challenge]
• High cost of developing imaging reagents
• For a full, detailed list, view our report

[Market trend]
• Increasing number of strategic collaborations
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Overview

PART 05: Market landscape
• Overview
• Market size and forecast
• Five forces analysis

PART 06: Segmentation by product type
• Overview
• Contrast reagents
• Nuclear imaging reagents

PART 07: Segmentation by geography
• Overview
• Americas
• EMEA
• APAC

PART 08: Decision framework

PART 09: Drivers and challenges
• Market drivers
• Market challenges

PART 10: Market trends
• Increasing number of strategic collaborations
• Increasing number of product approvals
• Increasing R&D focus on nanotechnology-based imaging reagents

PART 11: Vendor landscape
• Competitive landscape

PART 12: Key vendor analysis
• Bayer
• Bracco Diagnostics
• GE Healthcare
• Guerbet Group
• Lantheus Medical Imaging
• Other prominent vendors

PART 13: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Global medical imaging reagents market: Segmentation
Exhibit 02: Global medical imaging reagents market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global medical imaging reagents market: Segmentation by product type 2016 (% share)
Exhibit 05: Global contrast reagents market 2016-2021 ($ millions)
Exhibit 06: Global contrast reagents market: Segmentation by product type 2016 (% share)
Exhibit 07: Major iodinated contrast reagents
Exhibit 08: Global Iodinated contrast reagents market 2016-2021($ millions)
Exhibit 09: Major gadolinium contrast reagents
Exhibit 10: Global gadolinium contrast reagents market 2016-2021 ($ millions)
Exhibit 11: Major microbubbles contrast reagents
Exhibit 12: Global microbubbles contrast reagents market 2016-2021 ($ millions)
Exhibit 13: Global barium-based contrast reagents market 2016-2021 ($ millions)
Exhibit 14: Major nuclear imaging reagents
Exhibit 15: Global nuclear imaging reagents market 2016-2021 ($ millions)
Exhibit 16: Global medical imaging reagents market: Segmentation by geography 2016 (% share)
Exhibit 17: Medical imaging reagents market in Americas 2016-2021 ($ millions)
Exhibit 18: Medical imaging reagents market in EMEA 2016-2021 ($ millions)
Exhibit 19: Medical imaging reagents market in APAC 2016-2021 ($ millions)
Exhibit 20: Number of MRI exams performed by hospitals and ASCs per 1,000 people 2013-2015
Exhibit 21: Number of CT exams performed by hospitals and ASCs per 1,000 people 2013-2015
Exhibit 22: Global medical imaging reagents market: Competitive structure analysis 2016
Exhibit 23: Bayer: Key highlights
Exhibit 24: Bayer: Strength assessment
Exhibit 25: Bayer: Strategy assessment
Exhibit 26: Bayer: Opportunity assessment
Exhibit 27: Bracco Diagnostics: Key highlights
Exhibit 28: Bracco Diagnostics: Strength assessment
Exhibit 29: Bracco Diagnostics: Strategy assessment
Exhibit 30: Bracco Diagnostics: Opportunity assessment
Exhibit 31: GE Healthcare: Key highlights
Exhibit 32: GE Healthcare: Strength assessment
Exhibit 33: GE Healthcare: Strategy assessment
Exhibit 34: GE Healthcare: Opportunity assessment
Exhibit 35: Guerbet Group: Key highlights
Exhibit 36: Guerbet Group: Strength assessment
Exhibit 37: Guerbet Group: Strategy assessment
Exhibit 38: Guerbet Group: Opportunity assessment
Exhibit 39: Lantheus Medical Imaging: Key highlights
Exhibit 40: Lantheus Medical Imaging: Strength assessment
Exhibit 41: Lantheus Medical Imaging: Strategy assessment
Exhibit 42: Lantheus Medical Imaging: Opportunity assessment



【掲載企業】

Bayer, Bracco Diagnostics, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging, Cardinal Health, Curium, DONGKOOK, Eli Lilly and Company, Isologic Innovative Radiopharmaceuticals, Jiangsu Hengrui Medicine, Piramal Imaging, and SHINE Medical Technologies.


【資料のキーワード】

医療画像、試薬

★調査レポート[医療画像用試薬の世界市場2017-2021] (Global Medical Imaging Reagents Market 2017-2021 / IRTNTR14974)販売に関する免責事項
[医療画像用試薬の世界市場2017-2021] (Global Medical Imaging Reagents Market 2017-2021 / IRTNTR14974)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆